BBOT
BridgeBio Oncology Therapeutics, Inc.
NASDAQ: BBOT · HEALTHCARE · BIOTECHNOLOGY
$8.41
+4.34% today
Updated 2026-04-30
Market cap
$702.69M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.30
Dividend yield
—
52W range
$8 – $15
Volume
0.3M
BridgeBio Oncology Therapeutics, Inc. (BBOT) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | $144281.00 | $144578.00 | $332894.00 | $194.42M |
| Cash & equivalents | — | — | $250000.00 | $1.70M |
| Current assets | — | — | $3.94M | $1.95M |
| Total liabilities | $162638.00 | $166455.00 | $396463.00 | $5.71M |
| Current liabilities | $162638.00 | $166455.00 | $396463.00 | $187515.00 |
| Long-term debt | — | — | — | — |
| Shareholder equity | $-18357.00 | $-21877.00 | $-63569.00 | $188.72M |
| Retained earnings | $-43357.00 | $-46877.00 | $-88569.00 | $-3.73M |
| Accounts receivable | — | — | — | — |
| Inventory | — | — | — | — |
| Goodwill | — | — | — | — |